Shire Deal

[Anonymous]

If Rick G screws up the Shire deal. This will be the end.

 

[Anonymous]

If Rick G screws up the Shire deal. This will be the end.

THE END OF THE WORLD? HAS ANYONE INFORrMED THOSE LEPRACHAUNS? THey SuRELY DONT zWANT ARMAGGEDON!

 

[Anonymous]

They are not sitting on a pot of gold!

 

[Anonymous]

Re: Shire Deal or Lets Make A Deal? Which is next?

They are not sitting on a pot of gold yet!

Maybe behind door number two

 

[Anonymous]

Re: Shire Deal or Lets Make A Deal? Which is next?

Maybe behind door number two

Or door number three

 

[Anonymous]

Re: Shire Deal or Lets Make A Deal? Which is next?

Or door number three

This is awesome...............it will be great!
I am looking forward to it!

 

[Anonymous]

AbbVie won't buy Shire, it is simply too expensive given AbbVie stands to gain little from the deal and Shire is probably better off on its own so will resist all the way.

 

[Anonymous]

Gotta love the value play here. Combined share since separation flirting with$100/share. May want to place some puts to protect the gains especially on LTG.

 

[Anonymous]

£51.15 - pah - get lost AbbVie, your deal just fell through!

 

[Anonymous]

Pound sand and Pay your taxes!

 

[Anonymous]

Shire deal wont happen metabolics the clock is ticking fast get plan b in place and hope for a good severance

 

[Anonymous]

Re: Shire Deal or Let's Make A Deal?

Shire deal wont happen metabolics the clock is ticking fast get plan b in place and hope for a good severance

Maybe behind door number two

 

[Anonymous]

If the deal goes through, does all of Chicago R&D move to Boston?
Does Worcester get consolidated with Shire's Lexington site.
Discuss.

 

[Anonymous]

What happens to Shire sales force if this goes down?

 

[Anonymous]

If Rick G screws up the Shire deal. This will be the end.

How can he fail? He has such a great education!

 

[Anonymous]

He never graduated college.

 

[Anonymous]

So he lied and said he graduated. Rick please resign.

 

[Anonymous]

So he lied and said he graduated. Rick please resign.

I guess if are best buds with MW you can get away with anything.

 

[Anonymous]

I guess if are best buds with MW you can get away with anything.

Shire was sold to Meijer last week.

 

[Anonymous]

Pharmaceutical company Shire has been valued at £30bn in a raised bid from the US rival which has been trying to take control of the business for weeks.

The chairman of Chicago-based AbbVie urged Shire shareholders to back its fourth offer for the FTSE 100 company, which is best known for its controversial treatment for attention deficit hyperactivity disorder (ADHD).

Richard Gonzalez, who is also chief executive of AbbVie, said: "This transaction is a combination of two leading companies with leadership positions in specialty pharmaceuticals that would create a global market leader with unique characteristics and a compelling investment thesis.

"AbbVie has made a compelling offer to Shire that creates immediate and long-term value to shareholders of both companies. We think its shareholders should strongly encourage the Shire board to engage in constructive dialogue with AbbVie," Gonzalez said.

The latest offer values each Shire share at £51.15 – above the current price of £46.30 – and is based on a mixture of cash and AbbVie shares. This compares with the £46.11 a share in the offer made public in June which prompted Shire's boss Flemming Ørnskov to set out a plan to double sales over the next seven years in an attempt to remain independent.

Ørnskov, who has been running Shire since May 2013, set out a plea to remain independent last month even as he admitted that he could not close the door on bids.

The offer for Shire, which moved its tax base to Dublin in 2008, follows the ill-fated attempt by US pharmaceutical company Pfizer to take control of FTSE 100 company AstraZeneca.

AbbVie, which under takeover panel rules has until 18 July to make a formal offer or walk away for six months, said it has spoken to a "large number of shareholders" about the potential offer for Shire.

The US company, which if it bought Shire could potentially make huge tax savings, said it was "willing to move quickly and cooperatively to engage with Shire with a view to achieving a transaction for the benefit of all shareholders".

Shire, which was not informed of the raised offer by AbbVie, urged its shareholder to take no action. "The board of Shire will meet to consider the proposal and a further announcement will be made in due course," Shire said.